Literature DB >> 17197809

Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients.

Vincent Mallet1, Pierre Blanchard, Virginie Verkarre, Anaïs Vallet-Pichard, Hélène Fontaine, Caroline Lascoux-Combe, Stanislas Pol.   

Abstract

OBJECTIVE: To describe and explain the syndrome of HIV-associated cryptogenic liver disease in eight consecutive patients suffering from portal hypertension.
METHODS: The study was undertaken at a liver disease centre in Paris and involved eight of 97 consecutive HIV-infected patients presenting abnormal liver function tests and/or symptomatic portal hypertension of unknown origin. Serology, pathology, and liver function tests were performed.
RESULTS: A clear nodular architecture corresponding to nodular regenerative hyperplasia was observed in seven patients and suggested in one, based on the presence of sinusoidal dilatation in a clinical context of portal hypertension, without overt liver disease.
CONCLUSIONS: Nodular regenerative hyperplasia appears to be a new cause of portal hypertension in HIV-infected patients. This syndrome can be of critical importance as patients can be exposed to the significant complications of portal hypertension and to refractory ascites which may require liver transplantation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17197809     DOI: 10.1097/QAD.0b013e3280119e47

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  20 in total

1.  Didanosine Exposure and Noncirrhotic Portal Hypertension in a HIV Clinic in North America: a Follow-up Study.

Authors:  Edward R Cachay; Michael R Peterson; Miguel Goicoechea; William C Mathews
Journal:  Br J Med Med Res       Date:  2011

2.  Nodular regenerative hyperplasia of the liver associated with didanosine persists for years even after its interruption.

Authors:  Daniel Hofmaenner; Helen Kovari; Achim Weber; Dominik Weishaupt; Roberto F Speck
Journal:  BMJ Case Rep       Date:  2011-05-03

Review 3.  Nodular regenerative hyperplasia: evolving concepts on underdiagnosed cause of portal hypertension.

Authors:  Marek Hartleb; Krzysztof Gutkowski; Piotr Milkiewicz
Journal:  World J Gastroenterol       Date:  2011-03-21       Impact factor: 5.742

4.  The development of hepatoportal sclerosis and portal hypertension due to didanosine use in HIV.

Authors:  Thomas D Schiano; Alison Uriel; Douglas T Dieterich; M Isabel Fiel
Journal:  Virchows Arch       Date:  2010-11-06       Impact factor: 4.064

Review 5.  Liver disease in the HIV-infected individual.

Authors:  Jennifer C Price; Chloe L Thio
Journal:  Clin Gastroenterol Hepatol       Date:  2010-09-17       Impact factor: 11.382

6.  Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs study.

Authors:  Helen Kovari; Caroline A Sabin; Bruno Ledergerber; Lene Ryom; Signe W Worm; Colette Smith; Andrew Phillips; Peter Reiss; Eric Fontas; Kathy Petoumenos; Stéphane De Wit; Philippe Morlat; Jens D Lundgren; Rainer Weber
Journal:  Clin Infect Dis       Date:  2012-10-22       Impact factor: 9.079

7.  [Noncirrhotic portal hypertension in a human immunodeficiency virus (HIV) infected adolescent].

Authors:  Aída de Fátima Thomé Barbosa Gouvêa; Daisy Maria Machado; Suênia Cordeiro de Vasconcelos Beltrão; Fabiana Bononi do Carmo; Regina Helena Guedes Motta Mattar; Regina Célia de Menezes Succi
Journal:  Rev Paul Pediatr       Date:  2015-03-27

8.  Alterations in Serum Zinc and Polyunsaturated Fatty Acid Concentrations in Treatment-Naive HIV-Diagnosed Alcohol-Dependent Subjects with Liver Injury.

Authors:  Vatsalya Vatsalya; Matthew C Cave; Rajarshi Kumar; Shweta Srivastava; Sujita Khanal; Alfred B Jenson; Melanie L Schwandt; Shirish S Barve; Vijay A Ramchandani; Craig J McClain
Journal:  AIDS Res Hum Retroviruses       Date:  2018-12-11       Impact factor: 2.205

Review 9.  Human immunodeficiency virus and nodular regenerative hyperplasia of liver: A systematic review.

Authors:  Archita Sood; Mariana Castrejón; Sammy Saab
Journal:  World J Hepatol       Date:  2014-01-27

10.  Anticoagulant therapy for nodular regenerative hyperplasia in a HIV-infected patient.

Authors:  Florian Bihl; Filip Janssens; Francoise Boehlen; Laura Rubbia-Brandt; Antoine Hadengue; Laurent Spahr
Journal:  BMC Gastroenterol       Date:  2010-01-18       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.